Giant leap for Exoskeleton tech
Last week, the German healthcare had a major victory for advanced technologies and its regulation. ReWalk Robotics achieved regulation, a giant leap forward for exoskeleton tech. Israel’s ReWalk is a developer of robotic exoskeletons, wearable devices worn to support for gait rehabilitation or locomotion assistance.
BARMER, one of Germany’s largest statutory health insurance providers, accepts a ruling from state courts that made exoskeletons considered eligible for direct disability compensation. The ruling gives eligible, insured patients with spinal cord injuries (SCIs) a legal basis to use an exoskeleton as an orthopaedic aid for direct disability compensation in Germany.
On Dealroom, we’ve mapped 24 exoskeleton tech startups, positioned to both capitalize from new regulatory momentum, and have a profound impact on the future of health and physiological rehab and motor enablement.
All but five of these companies were founded in the last ten years, as the pace of advancement in robotics technology accelerates. And StrongArm Technologies and Wandercraft are both actively hiring in multiple roles, having raised Series B and Series C in January respectively.
Dealroom tracks and categorizes over 102,000 health startups globally, that have raised over 60K rounds. Explore more health niches, including digital therapeutics, AI drug development, patient triage tech, dementia care, psychelic drugs, remote monitoring and much more.
And for regular insights and data on health and biotech, subscribe to our dedicated weekly newsletter: